Similar articles

• Curcumin prevents and reverses murine cardiac hypertrophy.

  Li HL, Liu C, de Couto G, Ouzounian M, Sun M, Wang AB, Huang Y, He CW, Shi Y, Chen X, Nghiem MP, Liu Y, Chen M, Dawood F, Fukuoka M, Maekawa Y, Zhang L, Leask A, Ghosh AK, Kirshenbaum LA, Liu PP. Li HL, et al. J Clin Invest. 2008 Mar;118(3):879-93. doi: 10.1172/JCI32865. J Clin Invest. 2008. Retraction in: J Clin Invest. 2009 Jul;119(7):2113. doi: 10.1172/jci32865r1 PMID: 18292803 Free PMC article. Retracted.
• In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy.

  Liu Y, Liu Q, Liu Y, Ju F, Ma Q, He Q. Liu Y, et al. J Photochem Photobiol B. 2019 Oct;199:111619. doi: 10.1016/j.jphotobiol.2019.111619. Epub 2019 Aug 27. J Photochem Photobiol B. 2019. PMID: 31622787
• Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment.

  Ray A, Rana S, Banerjee D, Mitra A, Datta R, Naskar S, Sarkar S. Ray A, et al. Toxicol Appl Pharmacol. 2016 Jan 1;290:54-65. doi: 10.1016/j.taap.2015.11.011. Epub 2015 Nov 21. Toxicol Appl Pharmacol. 2016. PMID: 26612707
• Proteasome inhibitors and cardiac cell growth.

  Hedhli N, Depre C. Hedhli N, et al. Cardiovasc Res. 2010 Jan 15;85(2):321-9. doi: 10.1093/cvr/cvp226. Epub 2009 Jul 3. Cardiovasc Res. 2010. PMID: 19578073 Free PMC article. Review.
• Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes.

  Katanasaka Y, Sunagawa Y, Hasegawa K, Morimoto T. Katanasaka Y, et al. Biol Pharm Bull. 2013;36(1):13-7. doi: 10.1248/bpb.b212022. Biol Pharm Bull. 2013. PMID: 23302632 Review.